Search Form
First, enter a politician or zip code
Now, choose a category

Public Statements

Public Statements

Date Title Officials Location
Oct. 9, 2014 Sanders Investigating Drug Prices Sen. Bernard Sanders Burlington, VT
Oct. 2, 2014 Letter to Brian Lortie, President at Endo International PLC - Investigating Staggering Price Increases for Generic Drugs Sen. Bernard Sanders Washington, DC
Oct. 2, 2014 Letter to Umang Vohra, Executive Vice President of Dr. Reddy's Laboratories LTD - Investigating Staggering Price Increases for Generic Drugs Sen. Bernard Sanders Washington, DC
Oct. 2, 2014 Cummings and Sanders Investigate Staggering Price Increases for Generic Drugs Sen. Bernard Sanders Washington, DC
Oct. 2, 2014 Letter to Erez Vigodman, President and CEO of Teva Pharmaceutical Industries - Investigating Staggering Price Increases for Generic Drugs Sen. Bernard Sanders Washington, DC
Oct. 2, 2014 Letter to Paul Campanelli, CEO of Par Pharmaceutical Companies - Investigating Staggering Price Increases for Generic Drugs Sen. Bernard Sanders Washington, DC
Oct. 2, 2014 Letter to Joseph Renner, CEO of Zydus Pharmaceuticals - Investigating Staggering Price Increases for Generic Drugs Sen. Bernard Sanders Washington, DC
Oct. 2, 2014 Letter to Jeffrey Aronin, Chairman and CEO of Marathon Pharmaceuticals - Investigating Staggering Price Increases for Generic Drugs Sen. Bernard Sanders Washington, DC
Oct. 2, 2014 Letter to Jeffrey Watson, President of Apotex Corporation - Investigating Staggering Price Increases for Generic Drugs Sen. Bernard Sanders Washington, DC
Oct. 2, 2014 Letter to Heather Bresch, CEO of Mylan - Investigating Staggering Price Increases for Generic Drugs Sen. Bernard Sanders Washington, DC
Oct. 2, 2014 Letter to Jeffrey Glazer, President and CEO of Heritage Pharmaceuticals - Investigating Staggering Price Increases for Generic Drugs Sen. Bernard Sanders Washington, DC
Oct. 2, 2014 Letter to Michael Raya, President and CEO of West-Ward Pharmaceutical Corporation - Investigating Staggering Price Increases for Generic Drugs Sen. Bernard Sanders Washington, DC
Oct. 2, 2014 Letter to Dilip Shanghvi, Managing Director of Sun Pharmaceutical Industries - Investigating Staggering Price Increases for Generic Drugs Sen. Bernard Sanders Washington, DC
Oct. 2, 2014 Letter to Brenton Saunders, CEO and President of Actavis PLC - Investigating Staggering Price Increases for Generic Drugs Sen. Bernard Sanders Washington, DC
Oct. 2, 2014 Letter to Carole Ben-Maimon, President of Global Pharmaceuticals - Investigating Staggering Price Increases for Generic Drugs Sen. Bernard Sanders Washington, DC
Oct. 2, 2014 Letter to Arthur Bedrosian, President and CEO of Lannett Company - Investigating Staggering Price Increases for Generic Drugs Sen. Bernard Sanders Washington, DC
Sept. 17, 2014 Statements on Introduced Bills and Joint Resolutions Sen. Patrick Leahy Washington, DC
Sept. 17, 2014 Klobuchar, Bipartisan Group of Senators Introduce Legislation to Combat Drug Addiction and Support Recovering Addicts Sen. Patrick Leahy Washington, DC
Sept. 12, 2014 Leahy, Sanders, Welch: Grant Will Help Expand the Lund Center's Help to Pregnant and Postpartum Women in Conquering Substance Abuse Rep. Peter Welch Unknown
Sept. 12, 2014 Leahy, Sanders, Welch: Grant Will Help Expand the Lund Center's Help to Pregnant and Postpartum Women in Conquering Substance Abuse Sen. Patrick Leahy Unknown
Sept. 12, 2014 Leahy, Sanders, Welch: Grant Will Help Expand the Lund Center's Help to Pregnant and Postpartum Women in Conquering Substance Abuse Sen. Bernard Sanders Unknown
July 31, 2014 Statements on Introduced Bills and Joint Resolutions Sen. Patrick Leahy Washington, DC
July 30, 2014 House Passes Welch Legislation to Curb Prescription Drug Abuse and Ensure Timely Patient Access Rep. Peter Welch Unknown
July 29, 2014 Ensuring Patient Access and Effective Drug Enforcement Act of 2014 Rep. Peter Welch Washington, DC
July 18, 2014 Comment Of Senator Patrick Leahy (D-Vt.), Chairman, Senate Judiciary Committee, On The U.S. Sentencing Commission's Vote To Retroactively Apply Two-Level Reduction In Drug Quantity Table Sen. Patrick Leahy Unknown
July 16, 2014 Congressional Research Centennial Sen. Patrick Leahy Washington, DC
July 9, 2014 Comment of Senator Patrick Leahy (D-Vt.), Chairman, Senate Judiciary Committee, On President Obama's 2014 National Drug Control Strategy Sen. Patrick Leahy Unknown
June 3, 2014 Approach to Opioid Addiction Sen. Patrick Leahy Washington, DC
April 30, 2014 Hearing of the Senate Judiciary Committee - Oversight Of The Drug Enforcement Administration Sen. Patrick Leahy Washington, DC
April 30, 2014 Hearing of the Senate Judiciary Committee - Oversight Of The Drug Enforcement Administration Sen. Patrick Leahy Washington, DC
April 23, 2014 The Surge In Opioid And Heroin Addiction Looms As A Key Topic As Leahy Sets Oversight Hearing With Drug Enforcement Chief Sen. Patrick Leahy Unknown
April 23, 2014 Letter to Margaret Hamburg, Commissioner of the United States Food and Drug Administration - Recognize Naloxene as a Safe and Effective Opioid Overdose Reversal Drug for Over-the-Counter Use Rep. Peter Welch Washington, DC
April 3, 2014 Comment Of Senator Patrick Leahy On Governor Shumlin's Initiative On Opioid Prescription Medicine Sen. Patrick Leahy Unknown
March 27, 2014 Leahy's First Report To The Senate On Rutland Field Hg. On Heroin & Opioid Addiction Sen. Patrick Leahy Unknown
March 26, 2014 Heroin and Opioid Addiction Sen. Patrick Leahy Washington, DC
March 17, 2014 Hearing of the Senate Judiciary Committee - Community Solutions to Breaking the Cycle of Heroin and Opioid Addiction Sen. Patrick Leahy Washington, DC
March 13, 2014 VPR: FDA Approves Controversial New Painkiller Rep. Peter Welch Unknown
March 11, 2014 Letter to Margaret Hamburg, Commissioner of the Food and Drug Administration - Zohydro ER Rep. Peter Welch Washington, DC
Jan. 8, 2014 Senator Leahy Praises Governor Shumlin's Plan To Address Opiate Addiction Sen. Patrick Leahy Unknown
Nov. 8, 2013 Leahy Leads Coalition of Lawmakers in Welcoming the FDA's Release of Proposed Rules To Protect Consumers Using Generic Drugs Sen. Patrick Leahy Washington, DC
Nov. 6, 2013 Guest Column By Senator Patrick Leahy: Another Successful Vermont Drug Take Back Day Sen. Patrick Leahy Unknown
Aug. 15, 2013 US News - Rand Paul and Patrick Leahy: Join Us to Do Away With Mandatory Minimums Sen. Patrick Leahy Unknown
July 31, 2013 Hearing of the Senate Judiciary Committee - Nomination of B. Todd Jones Sen. Patrick Leahy Washington, DC
July 23, 2013 Hearing of the Senate Judiciary Committee - "Pay-for-Delay Deals: Limiting Competition and Costing Consumers" Sen. Patrick Leahy Washington, DC
July 3, 2013 Leahy Welcomes News That The FDA Will Move Forward With Proposed Rulemaking To Protect Consumers Using Generic Drugs Sen. Patrick Leahy Washington, DC
April 18, 2013 Letter to U.S. Secretary of State John Kerry - U.S.-Colombia Policy Rep. Peter Welch Unknown
July 9, 2012 Comment of Senator Patrick Leahy on the Food and Drug Administration Safety and Innovation Act Sen. Patrick Leahy Unknown
June 26, 2012 Food and Drug Administration Safety and Innovation Act of 2012--Continued Sen. Patrick Leahy Washington, DC
May 24, 2012 Food and Drug Administration Safety and Innovation Act Sen. Patrick Leahy Washington, DC
May 23, 2012 Food and Drug Administration Safety and Innovation Act Sen. Patrick Leahy Washington, DC
May 23, 2012 Leahy-Grassley Bill to Increase Penalties for Counterfeit Drugs Adopted in FDA Bill Sen. Patrick Leahy Unknown
March 29, 2012 Senate Judiciary Committee Approves Leahy, Grassley Bill to Reauthorize Drug Free Communities Program Sen. Patrick Leahy Washington, DC
March 13, 2012 Letter to The Honorable Margaret Hamburg, Commissioner of Food and Drug Administration Sen. Bernard Sanders Washington, DC
March 13, 2012 Letter to The Honorable Margaret Hamburg, Commissioner of Food and Drug Administration Sen. Patrick Leahy Washington, DC
March 7, 2012 Senate Approves Leahy-Grassley Bill to Increase Penalties for Counterfeit Drugs Sen. Patrick Leahy Washington, DC
March 6, 2012 Leahy, Grassley Introduce Bill to Reauthorize Drug Free Communities Program Sen. Patrick Leahy Washington, DC
March 6, 2012 Counterfeit Drug Penalty Enhancement Act of 2011 Sen. Patrick Leahy Washington, DC
Feb. 2, 2012 Leahy, Sanders, Welch: In Another Milestone For Health Care Reform, In 2011, Vermonters With Medicare Saved More Than $4.8 M. On Their Prescription Drugs Sen. Patrick Leahy Washington, DC
Feb. 2, 2012 Sanders Backs Bill to Relieve Prescription Drug Shortages Sen. Bernard Sanders Washington, DC
Feb. 2, 2012 Leahy, Sanders, Welch: In Another Milestone For Health Care Reform, In 2011, Vermonters With Medicare Saved More Than $4.8 M. On Their Prescription Drugs Sen. Bernard Sanders Washington, DC
Feb. 2, 2012 Leahy, Sanders, Welch: In Another Milestone For Health Care Reform, In 2011, Vermonters With Medicare Saved More Than $4.8 M. On Their Prescription Drugs Rep. Peter Welch Washington, DC
Nov. 17, 2011 Statements on Introduced Bills and Joint Resolutions Sen. Patrick Leahy Washington, DC
Nov. 17, 2011 Proposal for Bipartisan, Bicameral Bill To Increase Penalties For Counterfeit Drugs Sen. Patrick Leahy Washington, DC
Nov. 3, 2011 Motion to Instruct Conferees on H.R. 2112, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012 Rep. Peter Welch Washington, DC
Nov. 2, 2011 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2012 Sen. Patrick Leahy Washington, DC
Oct. 31, 2011 Leahy Welcomes President's Actions Targeting Prescription Drug Shortages Sen. Patrick Leahy Washington, DC
Oct. 12, 2011 United States-Korea Free Trade Agreement Implementation Act--Continued Sen. Bernard Sanders Washington, DC
Oct. 6, 2011 Letter to theJoint Select Committee on Deficit Reduction (Supercommittee) Rep. Peter Welch Washington, DC
July 28, 2011 Leahy-Chaired Panel Approves Bill To Make Designer Drugs Known As "Bath Salts" Illegal Sen. Patrick Leahy Washington, DC
July 21, 2011 Letter to Dr. Margaret A. Hamburg, Commissioner, Food and Drug Administration Sen. Patrick Leahy Washington, DC
June 27, 2011 The Budget Sen. Bernard Sanders Washington, DC
June 22, 2011 The Hill - 'House Republican Signs on to Democrats' Medicare Drug Savings Proposal' Rep. Peter Welch Unknown
June 20, 2011 At Barre Senior Center Welch Announces Bipartisan Legislation to Lower Prescription Drug Prices and Cut the Deficit Rep. Peter Welch Unknown
June 16, 2011 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act. 2012 Rep. Peter Welch Washington, DC
June 16, 2011 Letter to The Honorable Margaret Hamburg, Commissioner, Food and Drug Administration Sen. Bernard Sanders Washington, DC
May 24, 2011 Hearing of the Crime and Terrorism Subcommittee of the Senate Judiciary Committee - "Responding to the Prescription Drug Epidemic: Strategies for Reducing Abuse, Misuse, Diversion, and Fraud" Sen. Patrick Leahy Washington, DC
May 12, 2011 Welch Launches Bipartisan Organization to Make Drugs More Affordable and Lower Health Care Spending Rep. Peter Welch Washington, DC
April 19, 2011 Comment Of Senator Patrick Leahy On The Administration's National Strategy To Address Prescription Drug Abuse Sen. Patrick Leahy Unknown
March 14, 2011 Comments Of Senator Patrick Leahy On "60 Minutes" Investigation Into The Counterfeit Drugs Market Sen. Patrick Leahy Unknown
Feb. 22, 2011 Letter to The Honorable Daniel Inouye, Chairman of the Senate Appropriations Committee Sen. Bernard Sanders Washington, DC
Dec. 8, 2010 Public Safety Employer-Employee Cooperation Act of 2009 Sen. Bernard Sanders Washington, DC
Sept. 5, 2010 Senator Leahy Comments On State Department Report On Merida Funding And The Leahy Human Rights Conditions Sen. Patrick Leahy Unknown
Aug. 30, 2010 Leahy: Drug Abuse Program Grants To Vermont Will Help "Drill Down' On Solutions To Substance Abuse And Drug-Related Crime Sen. Patrick Leahy Unknown
July 28, 2010 Comment Of Senator Leahy On Final Passage Of The Fair Sentencing Act Of 2010 Sen. Patrick Leahy Unknown
June 14, 2010 Reaction To The State's Decision To Let Vermonters In The State's VPharm Program Keep Their Medicare Prescription Drug Rebate Checks Sen. Patrick Leahy Unknown
June 14, 2010 Statement: Sanders on Medicare Prescription Drug Rebates Sen. Bernard Sanders Washington, DC
June 11, 2010 Vermont Senators Statement on Senior Prescription Drug Rebates Sen. Patrick Leahy Washington, DC
June 11, 2010 Prescription Drug Rebates Sen. Bernard Sanders Washington, DC
June 7, 2010 Health Care Law Improves Prescription Drug Coverage Sen. Patrick Leahy Burlington, VT
June 7, 2010 Release: Health Care Law Improves Prescription Drug Coverage Sen. Bernard Sanders Burlington, VT
June 7, 2010 Making Rx Drugs More Affordable for Seniors Sen. Bernard Sanders Unknown
May 25, 2010 Feingold Introduces Welch Prescription Drug Price Negotiation Act in Senate Rep. Peter Welch Unknown
May 11, 2010 Comment On Release Of The Administration's 2010 National Drug Control Strategy Sen. Patrick Leahy Washington, DC
April 20, 2010 Justice John Paul Stevens Sen. Patrick Leahy Washington, DC
April 15, 2010 Judiciary Committee Advances Leahy, Grassley Drug Free Communities Bill Sen. Patrick Leahy Washington, DC
March 22, 2010 Hearing of the Senate Judiciary Committee: "Effective Community Efforts To Counter Drug-Related Crime in Rural America" Sen. Patrick Leahy Barre, Vermont
March 17, 2010 Fair Sentencing Act of 2009 Sen. Patrick Leahy Washington, DC
March 12, 2010 Leahy To Chair Barre Hearing Of Senate Judiciary Committee Sen. Patrick Leahy Unknown
March 12, 2010 Leahy To Chair Barre Hearing Of Senate Judiciary Committee Sen. Patrick Leahy Unknown
March 3, 2010 Tax Extenders Act Of 2009 Sen. Bernard Sanders Washington, DC
Skip to top
Back to top